Physician profile
Michael R Klingerman
NPI 1285621557
$1,382.23
in general payments reported to CMS, 2019-2025
7 companies · $390 in 2025
The $390 reported for 2025 was more than what 91% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.88 · 2021: $58.01 · 2022: $29.41 · 2023: $371 · 2024: $454 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,214.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $450.59 | 2024-2025 | |
| Abbvie INC. | $293.83 | 2023-2025 | |
| Merz North America, INC. | $288.29 | 2021-2023 | Xeomin |
| Revance Therapeutics, INC. | $224.79 | 2024 | Daxxify |
| Janssen Pharmaceuticals, INC | $92.58 | 2019-2022 | |
| Csl Behring | $16.71 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Klingerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.